申请人:Sandoz Ltd.
公开号:US05210072A1
公开(公告)日:1993-05-11
The 3-O-[N-acetylmuramyl-D-isoglutaminyl]-1,2-di-O-palmitoyl-sn-glycerol derivative of formula I ##STR1## wherein the carbon atom marked with an asterisk * has the R or, respectively, the S configuration, possesses interesting pharmacological, in particular immunomodulating properties. It is particularly useful as an immunomodulant, as an adjuvant in vaccines and as a suppressing agent for IgE formation in e.g. type I allergies and atopical dermatitises. It is obtained by deprotection of a corresponding compound having one or more hydroxy group(s) in protected form.
公式I的3-O-[N-乙酰基穆拉酰-D-异谷氨酰]-1,2-二-O-棕榈酰-sn-甘油衍生物,其中用星号*标记的碳原子具有R或S构型,具有有趣的药理学特性,特别是免疫调节特性。它特别适用作为免疫调节剂,在疫苗中作为辅助剂,并且作为抑制IgE形成的药剂,例如在I型过敏和特应性皮炎中。它是通过去保护具有一个或多个羟基的相应化合物获得的。